High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels.
Transl Psychiatry. 2019 Nov 20;9(1):303. doi: 10.1038/s41398-019-0633-0.
Transl Psychiatry. 2019.
PMID: 31745072
Free PMC article.
Clinical Trial.